amlexanox has been researched along with clobetasol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Rodríguez, M; Rubio, JA; Sanchez, R | 1 |
Bailey, J; McCarthy, C; Smith, RF | 1 |
Dorocka-Bobkowska, B; Ślebioda, Z; Łukaszewska-Kuska, M | 1 |
2 review(s) available for amlexanox and clobetasol
Article | Year |
---|---|
Clinical inquiry. What is the most effective way to treat recurrent canker sores?
Topics: Administration, Topical; Aminopyridines; Anti-Allergic Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Beclomethasone; Cautery; Clobetasol; Eupatorium; Humans; Mouthwashes; Pain; Phytotherapy; Plant Preparations; Secondary Prevention; Stomatitis, Aphthous; Vitamin B 12 | 2011 |
The effectiveness of topical forms of dexamethasone in the treatment of oral lichen planus- A systematic review.
Topics: Administration, Topical; Aminopyridines; Amitriptyline; Clobetasol; Dexamethasone; Humans; Ketoconazole; Lichen Planus, Oral; Methylene Blue; Mouthwashes; Thalidomide | 2022 |
1 trial(s) available for amlexanox and clobetasol
Article | Year |
---|---|
Effectiveness of two oral pastes for the treatment of recurrent aphthous stomatitis.
Topics: Aminopyridines; Analysis of Variance; Anti-Allergic Agents; Anti-Inflammatory Agents; Clobetasol; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain Measurement; Stomatitis, Aphthous | 2007 |
1 other study(ies) available for amlexanox and clobetasol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |